Cognitive Pharmaceuticals Ltd.
This article was originally published in Start Up
Executive Summary
Cognitive Pharmaceuticals Ltd. is developing a muscarinic agonist that it believes will replace acetylcholine and so result in immediate improvement in memory for Alzheimer's patients.